TGFB1 and multiple sclerosis: Increased TGF-β1 plasma levels have, for example, been found in patients with multiple sclerosis and are further increased by immunomodulatory treatment with interferon- β1b (Nicoletti et al. 1998), suggesting that the treatment might augment an already active endogenous anti-inflammatory mechanism.